Annual report pursuant to Section 13 and 15(d)

Earnings Per Share - Shares Used in the Earnings Per Share Computations (Details)

v3.24.2.u1
Earnings Per Share - Shares Used in the Earnings Per Share Computations (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
12 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2022
Earnings Per Share      
Net earnings, including noncontrolling interest $ 168,105 $ 285,442 $ 263,099
Less net earnings (loss) attributable to noncontrolling interest   179 (8,952)
Net earnings attributable to Bio-Techne 168,105 285,263 272,051
Income allocated to participating securities (33) (70) (121)
Income available to common shareholders $ 168,072 $ 285,193 $ 271,930
Weighted-average shares outstanding - basic (in shares) 157,708 157,179 156,874
Earnings per share - basic (in shares) $ 1.07 $ 1.81 $ 1.73
Income available to common shareholders $ 168,072 $ 285,193 $ 271,930
Dilutive effect of stock options and restricted stock units (in shares) 3,066 4,676 7,240
Weighted-average common shares outstanding - diluted (in shares) 160,774 161,855 164,114
Earnings per share - diluted (in shares) $ 1.05 $ 1.76 $ 1.66